Robert F. Kennedy, Jr. on the push for Meningitis Vaccine for Colorado College Students




Meningococcal meningitis is exceedingly rare. There were only about 390 cases in the U.S. last year. In a population of 319 million, that adds up to one case in 817,949 people. There were only three meningococcal meningitis cases in Colorado last year — one resulting in death.

So here is the math calculation that thoughtful student governments in Colorado must consider: If you inoculate Colorado’s 400,000 college students with the older vaccines, you can expect 4,000 serious adverse events and 12 dead.

Read more…

2 thoughts on “Robert F. Kennedy, Jr. on the push for Meningitis Vaccine for Colorado College Students

  1. Redpill1

    The paid for trolls are all over this article and instead of discrediting the information the focus was character assassination of Bobby Kennedy Jr. That seems to be the game plan of the vaccine makers and the CDC. In researching information on the meningitis vaccine I discovered this:

    There is no public health crisis. US population of 308 million, there are between 1400 and 3000 cases every year that fluctuate with a natural cycle. Between 10 and 15% of the cases are fatal with another 10 to 20% ending with brain damage or loss of limbs. as of 2011. There has been no increase in cases so there is no public health crisis. If you pay attention to the articles posted on the behalf of the pharmaceutical companies and the CDC you will see there are no stats stating there is a crisis. The cases of the meningitis has decreased more than 60 percent between 1998 and 2007 to less than 1 case in 100,000 people, which is an historic low in the U.S. To put this death rate into context, there are three times as many Americans, who die from heat stroke or drown in boating accidents12 every year than die from invasive meningococcal disease. (Cohn AC, MacNeil JR, Harrison LH et al. Changes in Neisseria meningitides Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease. Clinical Infectious Diseases January 15, 2010; 50(2): 184-191.)

    Go over to:
    There are only 7 studies on Bexsero and Trumenba.
    Guess who the study group is going to be. The high school and college kids. Not only doesn’t big pharma have to pay for volunteers, they make money on top of it.

    Bexsero was just approved in January after the ———-Disney False Flag hoax which terrorized the uninformed so this was going to be a shoe in. There are 7 studies-3 completed. One study was complete in 2007 which means it was on the back burner waiting for an opportunity and the other two were completed, 1- in March and the other in April of this year. Surprise!!!!
    For those who aren’t following:
    Bexsero was approved for distribution in JANUARY 2015
    The study on Bexsero was completed, 1 in MARCH 2015 and the other in APRIL 2015.

    Something is clearly wrong with this.

    Bexsero Meningococcal Group B
    Recombinant Neisseria meningitidis group B NHBA/NadA/fHbp proteins
    Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254
    Aluminium hydroxide
    Sodium chloride Histidine Sucrose Water for injections

    Trumenba has not been approved. Experimental Vaccines has some good information on meningitis vaccines: http://experimentalvaccines (dot) org/2013/12/19/princeton-university-experiments-on-5000-students/

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.